| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 6,049,000 | 2,399,000 | 2,262,000 | 2,639,000 | | Cost of Revenue | 546,000 | 333,000 | 340,000 | 362,000 | | | Gross Profit | 5,503,000 | 2,066,000 | 1,922,000 | 2,277,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,328,000 | 1,131,000 | 1,142,000 | 1,115,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,103,000 | 1,162,000 | 224,000 | 186,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,072,000 | (227,000) | 556,000 | 976,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,072,000 | (227,000) | 556,000 | 976,000 | | Interest Expense | 409,000 | 218,000 | 234,000 | 238,000 | | Income Before Tax | 663,000 | (445,000) | 322,000 | 738,000 | | Income Tax Expense | 133,000 | (197,000) | 74,000 | 233,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 530,000 | (248,000) | 248,000 | 505,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 530,000 | (248,000) | 248,000 | 505,000 | | Preferred Stock And Other Adjustments | (70,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $460,000 | ($248,000) | $248,000 | $505,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
